Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
37,686
-
Share change
-
+12,315
-
Total reported value
-
$158,276
-
Price per share
-
$4.00
-
Number of holders
-
20
-
Value change
-
+$51,725
-
Number of buys
-
4
-
Number of sells
-
2
Institutional Holders of TITAN PHARMACEUTICALS INC - COM NEW (TTNP) as of Q2 2025
As of 30 Jun 2025,
TITAN PHARMACEUTICALS INC - COM NEW (TTNP) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,686 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Marex Group plc, UBS Group AG, CoreCap Advisors, LLC, BANK OF AMERICA CORP /DE/, GROUP ONE TRADING LLC, OSAIC HOLDINGS, INC., BlackRock, Inc., and Global Wealth Strategies & Associates.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.